Free Trial

ZIVO Bioscience (ZIVO) Competitors

ZIVO Bioscience logo
$13.50 +0.99 (+7.91%)
As of 09:30 AM Eastern

ZIVO vs. MDWD, CHRS, CRBP, CGEN, GNLX, SAVA, BIOA, FTLF, PLX, and ACTU

Should you be buying ZIVO Bioscience stock or one of its competitors? The main competitors of ZIVO Bioscience include MediWound (MDWD), Coherus Oncology (CHRS), Corbus Pharmaceuticals (CRBP), Compugen (CGEN), Genelux (GNLX), Cassava Sciences (SAVA), BioAge Labs (BIOA), FitLife Brands (FTLF), Protalix BioTherapeutics (PLX), and Actuate Therapeutics (ACTU). These companies are all part of the "pharmaceutical products" industry.

ZIVO Bioscience vs. Its Competitors

ZIVO Bioscience (NASDAQ:ZIVO) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

ZIVO Bioscience has a beta of -0.03, indicating that its stock price is 103% less volatile than the S&P 500. Comparatively, MediWound has a beta of 0.27, indicating that its stock price is 73% less volatile than the S&P 500.

ZIVO Bioscience has higher earnings, but lower revenue than MediWound. MediWound is trading at a lower price-to-earnings ratio than ZIVO Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZIVO Bioscience$15.85K3,284.29-$7.78M-$2.58-5.23
MediWound$20.22M10.12-$30.22M-$2.64-6.99

In the previous week, ZIVO Bioscience and ZIVO Bioscience both had 1 articles in the media. ZIVO Bioscience's average media sentiment score of 0.67 beat MediWound's score of 0.05 indicating that ZIVO Bioscience is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ZIVO Bioscience
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MediWound
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

MediWound has a consensus price target of $32.25, suggesting a potential upside of 74.80%. Given MediWound's stronger consensus rating and higher probable upside, analysts clearly believe MediWound is more favorable than ZIVO Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZIVO Bioscience
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
MediWound
2 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33

12.8% of ZIVO Bioscience shares are owned by institutional investors. Comparatively, 46.8% of MediWound shares are owned by institutional investors. 48.9% of ZIVO Bioscience shares are owned by company insiders. Comparatively, 9.2% of MediWound shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

ZIVO Bioscience has a net margin of 0.00% compared to MediWound's net margin of -142.18%. ZIVO Bioscience's return on equity of 0.00% beat MediWound's return on equity.

Company Net Margins Return on Equity Return on Assets
ZIVO BioscienceN/A N/A -2,240.92%
MediWound -142.18%-96.71%-39.73%

Summary

ZIVO Bioscience beats MediWound on 8 of the 15 factors compared between the two stocks.

Get ZIVO Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZIVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZIVO vs. The Competition

MetricZIVO BioscienceBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$52.06M$345.16M$6.24B$10.56B
Dividend YieldN/AN/A5.74%4.88%
P/E Ratio-2.77N/A29.0627.16
Price / Sales3,284.29498.11554.75166.44
Price / CashN/A22.4437.4561.65
Price / Book-16.673.6812.326.45
Net Income-$7.78M-$127.22M$3.32B$276.51M
7 Day Performance0.37%-4.31%-1.25%-2.38%
1 Month Performance3.85%5.69%5.22%0.49%
1 Year Performance-18.23%2.96%61.35%30.73%

ZIVO Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZIVO
ZIVO Bioscience
0.5864 of 5 stars
$13.50
+7.9%
N/A-32.1%$52.06M$15.85K-2.7710Gap Up
MDWD
MediWound
1.764 of 5 stars
$18.47
+1.4%
$32.25
+74.6%
+9.0%$202.01M$20.22M-7.0080
CHRS
Coherus Oncology
4.1938 of 5 stars
$1.70
-1.7%
$4.51
+165.4%
+98.7%$201.07M$266.96M1.10330
CRBP
Corbus Pharmaceuticals
4.237 of 5 stars
$16.25
-0.4%
$45.43
+179.6%
+9.6%$200.01MN/A-3.4140Trending News
Analyst Forecast
Analyst Revision
CGEN
Compugen
1.8521 of 5 stars
$2.11
-5.8%
$4.00
+89.6%
+2.9%$199.89M$27.86M-9.5970Gap Up
High Trading Volume
GNLX
Genelux
1.4796 of 5 stars
$5.28
+0.6%
$20.33
+285.1%
+153.6%$198.31M$10K-6.1410News Coverage
Analyst Forecast
SAVA
Cassava Sciences
2.7175 of 5 stars
$4.43
+8.0%
$2.00
-54.9%
-86.2%$198.06MN/A-1.7430
BIOA
BioAge Labs
N/A$5.51
+0.2%
N/AN/A$197.18MN/A0.00N/AGap Up
FTLF
FitLife Brands
3.6099 of 5 stars
$20.05
-0.5%
$23.00
+14.7%
+18.2%$189.23M$64.47M23.8720
PLX
Protalix BioTherapeutics
2.1196 of 5 stars
$2.37
-3.3%
$15.00
+532.9%
+101.9%$188.97M$61.95M-18.23200Gap Up
ACTU
Actuate Therapeutics
1.3637 of 5 stars
$8.09
flat
$20.33
+151.3%
+3.5%$188.04MN/A0.0010

Related Companies and Tools


This page (NASDAQ:ZIVO) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners